Natural history and outcomes of MASLD and MetALD following non-alcoholic fatty liver disease reclassification in a Canadian cohort Yousef Almahanna; Francisco Idalsoaga; Luis Antonio Díaz; Ahmed Almohsen; Yi Nong Song; Amani Bajunayd; Rokhsana Mortuza; Jeemin Kim; Adrienne Abaya; Mohammad Qasim Khan; Juan Pablo Arab;

Examining the prevalence of hepatic steatosis and advanced fibrosis using non-invasive measures across Canada: A national estimate using the Canadian Health Measures Survey (CHMS) from 2009-2019 Jacob Romano; Jessica Burnside; Giada Sebastiani; Alnoor Ramji; Keyur Patel; Mark Swain; Sahar Saeed;

The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease Francisco Barrera; Javier Uribe; Nixa Olvares; Paula Huerta; Daniel Cabrera; Manuel Romero-Gómez;